Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 229

The DOI matches its Crossref record.

Inter-α-trypsin Inhibitor, a Covalent Protein-Glycosaminoglycan-Protein Complex

Open access
Zhuo, Lisheng, Hascall, Vincent C., Kimata, Koji·2004·Journal of Biological Chemistry

Abstract

The inter-α-trypsin inhibitor (IαI) 1The abbreviations used are: IαI, inter-α-trypsin inhibitor; UTI, urinary trypsin inhibitor; PαI, pre-α inhibitor; HC, heavy chain of IαI family molecules; PGP, protein-glycosaminoglycan-protein covalent complex; SHAP, serum-derived hyaluronan-associated protein; HA, hyaluronan; CS, chondroitin sulfate; TSG6 or TNFIP6, tumor necrosis factor-stimulated gene 6. family, a typical and classical example for protein-glycosaminoglycan-protein (PGP) complexes, occurs constitutively in plasma at relatively high concentrations and is a result of alternate combinations of three kinds of heavy chains with a common light chain, the bikunin proteoglycan. The family is characterized by the unique covalent linkage between the heavy chains and the chondroitin sulfate chain of bikunin. The early studies on the IαI family molecules have largely focused on the light chain (bikunin) that is fully responsible for their protease inhibitory activity. Since the mid-1980s, the structures of the family molecules have been clarified, and this led to the discovery of their complex interaction with another glycosaminoglycan, hyaluronan (HA), generating the serum-derived hyaluronan-associated protein (SHAP)-HA complex. Research from various directions has clarified many aspects of the biological function of the PGP complexes and provides a new vista on their interesting structure-function relationships, especially on their roles in inflammation. The IαI family was first identified as a trypsin inhibitor activity in nephropathic and pneumonopathic urine in 1909 and in normal urine in 1910. One member, the urinary trypsin inhibitor (UTI), was purified much later in the 1950s (1Shulman N.R. J. Biol. Chem. 1955; 213: 655-671Abstract Full Text PDF PubMed Google Scholar, 2Astrup T. Alkjoer K. Soardi F. Scand. J. Clin. Lab. Invest. 1959; 11: 181Crossref Scopus (17) Google Scholar) when it was independently isolated by researchers working on mucopolysaccharides, leukemia, and urolithiasis and was given many names: acid-stable protease inhibitor, prealbumin-like protease inhibitor, urinastatin, HI30, mingin, EDC1, uronic acid-rich protein, and nephrocalin (3Anderson A.J. Maclagan N.F. Biochem. J. 1955; 59: 638-644Crossref PubMed Scopus (19) Google Scholar, 4Chawla R.K. Wadsworth A.D. Rudman D. J. Immunol. 1978; 121: 1636-1639PubMed Google Scholar, 5Atmani F. Mizon J. Khan S.R. Eur. J. Biochem. 1996; 236: 984-990Crossref PubMed Scopus (52) Google Scholar). Based on the presence of two tandem Kunitz-type protease inhibitory domains, a structure-based name, bikunin, was suggested in 1990 to avoid confusion (6Gebhard W. Hochstrasser K. Fritz H. Enghild J.J. Pizzo S.V. Salvesen G. Biol. Chem. Hoppe Seyler. 1990; 371: 13-22PubMed Google Scholar). It is now known that bikunin (Mr ∼ 40,000) is a proteoglycan with a chondroitin sulfate (CS) chain and is the predominant protease inhibitor in urine. Bikunin is acid- and heat-stable and has an acidic pI between 2 and 3 largely due to the presence of sialic acid and CS. There were continuous efforts to find a serum cognate based on a hypothesis that UTI has a serum origin. In the 1970s, this led to the identification of serum IαI (7Proksch G.J. Lane J. Nordschow C.D. Clin. Biochem. 1973; 6: 200-206Crossref PubMed Scopus (27) Google Scholar), a macromolecule previously purified in the 1960s (8Heide K. Heimburger N. Haupt H. Clin. Chim. Acta. 1965; 11: 82Crossref Scopus (55) Google Scholar) (Fig. 1). Conclusive evidence for the identity came from the comparison of amino acid sequences in the 1980s (9Wachter E. Hochstrasser K. Hoppe Seyler's Z. Physiol. Chem. 1981; 362: 1351-1355Crossref PubMed Scopus (93) Google Scholar). Smaller components with inhibitor activity were released when IαI was treated in vitro in acidic conditions or with proteases, such as plasmin, trypsin, and elastase (10Dietl T. Dobrinski W. Hochstrasser K. Hoppe Seyler's Z. Physiol. Chem. 1979; 360: 1313-1318Crossref PubMed Scopus (54) Google Scholar, 11Pratt C.W. Pizzo S.V. Biochemistry. 1987; 26: 2855-2863Crossref PubMed Scopus (22) Google Scholar), or when incubated with inflammatory cells, in particular neutrophils, or cancer cells (12Pratt C.W. Swaim M.W. Pizzo S.V. J. Leukocyte Biol. 1989; 45: 1-9Crossref PubMed Scopus (30) Google Scholar, 13Kobayashi H. Gotoh J. Hirashima Y. Terao T. J. Biol. Chem. 1996; 271: 11362-11367Abstract Full Text Full Text PDF PubMed Scopus (47) Google Scholar). Cognate molecules with lower molecular weights were also found in serum, pre-α inhibitor (PαI), and inter-α-like trypsin inhibitor (14Enghild J.J. Thogersen I.B. Pizzo S.V. Salvesen G. J. Biol. Chem. 1989; 264: 15975-15981Abstract Full Text PDF PubMed Google Scholar). IαI was thought to be a single polypeptide chain until molecular biology techniques became available. Cell-free translation of liver mRNAs (15Bourguignon J. Vercaigne D. Sesboue R. Martin J.P. Salier J.P. FEBS Lett. 1983; 162: 379-383Crossref PubMed Sco

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.r300039200

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 229

Metadata

Authors
Zhuo, L., Hascall, V. C., & Kimata, K.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2004-09
Volume
279
Issue
37
Pages
38079-38082
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2016593129
Cited by
229
References
0
FWCI
3.56
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inter-α-trypsin Inhibitor, a Covalent Protein-Glycosaminoglycan-Protein Complex. https://app.cochat.ai/papers/10.1074/jbc.r300039200
The paper
Zhuo, L., Hascall, V. C., & Kimata, K. (2004). Inter-α-trypsin Inhibitor, a Covalent Protein-Glycosaminoglycan-Protein Complex. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.r300039200

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.